Speaker Profile
Ph.D., Co-Founder, BEVC
Biography
Rowan is a co-founder of BEVC an early stage VC firm investing in the intersection of life science, engineering, and computation. Over her career she has led the execution of dozens of equity investments and business deals. Rowan currently serves as an independent director at Natera, Inc. (NTRA), Cambridge Innovation Capital, Cellanome and CornerstoneAI. Previously she was regional Head of Johnson Johnson Innovation, Head of Healthcare Investing at GE Ventures and Head of Precision Diagnostics at GE Healthcare. Rowan was a partner at MDV for over a decade, investing in a wide variety of data-enabled companies including Adamas (IPO:ADMS), Pacific Biosciences (IPO:PACB), ParAllele Biosciences (Acq:AFFX), Personalis (IPO:PSNL), Sequenta (Acq:ADPT) and Verinata (Acq:ILMN). She was an early employee at Rosetta (IPO Acq:MRK) and Incyte (INCY) and is a co-founder of Initiate Studios. Rowan holds a PhD in Biochemistry from the University of Cambridge and carried out post-doctoral research at UCSF.
Talk
Atul Butte Company Competition Finals Judge
NA
AI and Data Sciences Showcase:
BEVC
Early-stage venture capital enabling exceptional founders. Focus at the intersection of life sciences, engineering, and computation.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 AI Company Showcase will provide a 15-30 minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
